Terns Pharmaceuticals, Inc. — Director's Dealing 2022

Jul 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2022-07-26

Reporting Person: Tripuraneni Radhika (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-26	Stock Option (Right to Buy)	$2.13	A	64000.00	Acquired	2032-07-25	Common Stock (64000.00)	Direct

Footnotes

F1: 1/3rd of the shares subject to the option vest on the first anniversary measured from July 26, 2022 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.